umr tirzepatide coverage MCT2D Tirzepatide for diabetes: on track
Description
[4] [8] Some patients may also experience diarrhoea, and bowel habits can fluctuate during treatment
Timeline: When Diarrhea Usually Stops Most people experience diarrhea most intensely during the first 24 weeks after starting GLP-1 therapy or increasing their dose
Some providers recommend methenamine hippurate as a non-antibiotic prophylactic option for patients who want to avoid long-term antibiotic use
G., Cowtan K., Features and development of Coot
